Vimarsana
Biggest News Aggregation in the World

Page 13 - Revascularization Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Revascularization Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Revascularization Device Today - Breaking & Trending Today

Comerica Bank Buys 320 Shares of Penumbra, Inc. (NYSE:PEN) - Vimarsana News

Comerica Bank Buys 320 Shares of Penumbra, Inc. (NYSE:PEN)

Comerica Bank lifted its stake in Penumbra, Inc. (NYSE:PEN – Get Rating) by 2.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,072 shares of the company’s stock after acquiring an additional 320 shares during the quarter. Comerica Bank’s holdings in Penumbra […]

Penumbra (NYSE:PEN) and Adynxx (OTCMKTS:ADYX) Financial Analysis - Vimarsana News

Penumbra (NYSE:PEN) and Adynxx (OTCMKTS:ADYX) Financial Analysis

Adynxx (OTCMKTS:ADYX – Get Rating) and Penumbra (NYSE:PEN – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk. Volatility and Risk Adynxx has a beta of 2.32, indicating that its […]

Comparing Penumbra (NYSE:PEN) & DarioHealth (NASDAQ:DRIO) - Vimarsana News

Comparing Penumbra (NYSE:PEN) & DarioHealth (NASDAQ:DRIO)

Penumbra (NYSE:PEN – Get Rating) and DarioHealth (NASDAQ:DRIO – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, risk and analyst recommendations. Insider & Institutional Ownership 80.5% of Penumbra shares are owned by institutional […]

Penumbra, Inc. (NYSE:PEN) Expected to Post Quarterly Sales of $206.27 Million - Vimarsana News

Penumbra, Inc. (NYSE:PEN) Expected to Post Quarterly Sales of $206.27 Million

Wall Street analysts expect Penumbra, Inc. (NYSE:PEN – Get Rating) to post sales of $206.27 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Penumbra’s earnings, with estimates ranging from $205.60 million to $206.96 million. Penumbra reported sales of $184.26 million in the same quarter last year, […]

Penumbra, Inc. (NYSE:PEN) Expected to Announce Quarterly Sales of $196.00 Million - Vimarsana News

Penumbra, Inc. (NYSE:PEN) Expected to Announce Quarterly Sales of $196.00 Million

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.